Trends in Vascular Tissue Engineering

Dear Colleagues,

Vascular disorders, including coronary artery disease (CAD), peripheral artery disease (PAD), cerebrovascular disease (CeVD), and rheumatic heart disease (RHD), represent the leading cause of morbidity and mortality worldwide. Specifically, more than 17 million people die due to complications of vascular disease each year, in which time more than 800,000 bypass surgeries are performed.

Vascular tissue engineering has gained significant attention in the field of biomedical research as a promising approach for treating vascular diseases. This cutting-edge area focuses on developing functional vascular tissues to replace or repair damaged blood vessels.

This Special Issue aims to showcase the latest advancements, breakthroughs, and innovations in the field of vascular tissue engineering and regenerative medicine. We invite researchers, scientists, and professionals from around the world to submit their original research papers, review articles, and short communications for consideration.

Topics of interest for this Special Issue include, but are not limited to, the following:

• Vascularization strategies and novel concepts;
• Stem cells in vascular tissue engineering;
• Biomaterials in vascular tissue engineering;

Novel techniques and technologies, such as 3D bioprinting, microfluidic systems, gene editing tools, and tissue-on-a-chip platforms, advancing vascular tissue engineering and regenerative medicine.

Dr. Michalis P. Katsimpoulas
Dr. Yuncheng Du
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• cardiovascular disease
• 3D bioprinting
• vascular grafts
• stem cells
• scaffolds